Founder, Chairman, Masimo
WHY: Founded Irvine patient monitoring company in 1989 that last year reported net income of $193M on sales of $853M. Masimo valued at nearly $8B. Kiani’s stock valued at around $900M.
RECENT: Company’s stock is up more than 50% over past year. Firm making a push into monitoring systems for opiod use, hoping to prevent accidental overdoses. Among early backers of Joe Biden’s campaign.
NOTABLE: Philanthropy geared toward children, health, and poverty alleviation. Started foundation to achieve zero preventable deaths by 2020.
